Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
By Payer Type, Private and Self-Pay Segment Accounts for 70% Market Share Private insurance and self-pay arrangements are projected to contribute 70% of the market in 2025, representing patients who access treatment through commercial health insurance or direct cash payment
What is the average out-of-pocket cost for GLP-1 weight loss without insurance
DOI: 10.3390/ph18020185
however, it is not yet approved for use Boehringer Ingelheim, a biopharmaceutical company headquartered in Ingelheim, Germany, has announced promising results from its Phase 3 SYNCHRONIZE-1 clinical trial testing survodutide
US$ 22.18
US$ 27.04
US$ 24.42
